Rockwell Medical Technologies Inc Sample Contracts

AutoNDA by SimpleDocs
COMMON STOCK PURCHASE WARRANT ROCKWELL MEDICAL, INC.
Common Stock Purchase Warrant • August 14th, 2023 • Rockwell Medical, Inc. • Pharmaceutical preparations • New York

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, Armistice Capital Master Fund Ltd. or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on July 10, 2028 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Rockwell Medical, Inc., a Delaware corporation (the “Company”), up to 3,750,000 shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). Capitalized terms not otherwise defined herein shall have the meanings set forth in the Warrant Inducement Agreement (as defined below).

SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • September 25th, 2020 • Rockwell Medical, Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of September 23, 2020, between Rockwell Medical, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).

RECITALS
Asset Purchase Agreement • July 24th, 1997 • Rockwell Medical Technologies Inc • Michigan
AMENDING AGREEMENT
License Agreement • March 21st, 2006 • Rockwell Medical Technologies Inc • Electromedical & electrotherapeutic apparatus
PRE-FUNDED COMMON STOCK PURCHASE WARRANT ROCKWELL MEDICAL, INC.
Security Agreement • June 2nd, 2022 • Rockwell Medical, Inc. • Pharmaceutical preparations

THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Rockwell Medical, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

EXHIBIT 10.2 EXHIBIT A
Registration Rights Agreement • June 23rd, 2006 • Rockwell Medical Technologies Inc • Electromedical & electrotherapeutic apparatus
ROCKWELL MEDICAL, INC. (a Michigan corporation) 6,500,000 Shares of Common Stock UNDERWRITING AGREEMENT
Underwriting Agreement • November 20th, 2014 • Rockwell Medical, Inc. • Electromedical & electrotherapeutic apparatus • New York
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • June 2nd, 2022 • Rockwell Medical, Inc. • Pharmaceutical preparations • New York

This Securities Purchase Agreement (this “Agreement”) is dated as of May 30, 2022, between Rockwell Medical, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).

RECITALS
Supply Agreement • May 17th, 2004 • Rockwell Medical Technologies Inc • Electromedical & electrotherapeutic apparatus • Delaware
1 EXHIBIT 10.14 LEASE
Lease • April 2nd, 2001 • Rockwell Medical Technologies Inc • Electromedical & electrotherapeutic apparatus
ARTICLE I. DEFINITIONS
Securities Purchase Agreement • June 23rd, 2006 • Rockwell Medical Technologies Inc • Electromedical & electrotherapeutic apparatus • New York
WITNESSETH:
License Agreement • April 1st, 2002 • Rockwell Medical Technologies Inc • Electromedical & electrotherapeutic apparatus • Michigan
ROCKWELL MEDICAL, INC. Shares of Common Stock (no par value per share) Controlled Equity OfferingSM Sales Agreement
Sales Agreement • April 11th, 2022 • Rockwell Medical, Inc. • Pharmaceutical preparations • New York

Rockwell Medical, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:

PRE-FUNDED COMMON STOCK PURCHASE WARRANT ROCKWELL MEDICAL, INC.
Pre-Funded Common Stock Purchase Warrant • June 2nd, 2022 • Rockwell Medical, Inc. • Pharmaceutical preparations

THIS PRE-FUNDED COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, ____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Closing Date (the “Initial Exercise Date”) until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from Rockwell Medical, Inc., a Delaware corporation (the “Company”), up to __________ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

COMMON STOCK PURCHASE WARRANT Rockwell Medical, Inc.
Common Stock Purchase Warrant • September 25th, 2020 • Rockwell Medical, Inc. • Pharmaceutical preparations

THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date set forth above (the “Initial Exercise Date”) and on or prior to 5:00 p.m. (New York City time) on ______________1 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Rockwell Medical, Inc., a Delaware corporation (the “Company”), up to ______ shares (as subject to adjustment hereunder, the “Warrant Shares”) of the Company’s Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).

EXHIBIT 4.10 EXCHANGE AGENT AGREEMENT
Exchange Agent Agreement • September 22nd, 2005 • Rockwell Medical Technologies Inc • Electromedical & electrotherapeutic apparatus
1 EXHIBIT 1.1 ROCKWELL MEDICAL TECHNOLOGIES, INC. UNDERWRITING AGREEMENT
Underwriting Agreement • July 24th, 1997 • Rockwell Medical Technologies Inc • New York
AutoNDA by SimpleDocs
Exhibit 99.2 REVOLVING NOTE
Revolving Note • March 31st, 2005 • Rockwell Medical Technologies Inc • Electromedical & electrotherapeutic apparatus

This Revolving Note evidences the Revolving Loans Letters of Credit and other indebtedness incurred by the Borrower under and pursuant to the Loan Agreement, to which reference is hereby made for a statement of the terms and conditions under which the Revolving Loan Maturity Date or any payment hereon may be accelerated. The holder of this Revolving Note is entitled to all of the benefits and security provided for in the Loan Agreement. All Revolving Loans shall be repaid by the Borrower on the Revolving Loan Maturity Date, unless payable sooner pursuant to the provisions of the Loan Agreement.

AMENDMENT NO. 1 TO LOAN AND SECURITY AGREEMENT
Loan and Security Agreement • March 28th, 2003 • Rockwell Medical Technologies Inc • Electromedical & electrotherapeutic apparatus • Maryland
5,833,334 Shares ROCKWELL MEDICAL, INC. Common Stock PURCHASE AGREEMENT
Purchase Agreement • June 20th, 2019 • Rockwell Medical, Inc. • Electromedical & electrotherapeutic apparatus • New York

Rockwell Medical, Inc., a Michigan corporation (the “Company”), proposes to sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 5,833,334 shares (the “Firm Shares”) of common stock, no par value per share (the “Common Stock”), of the Company. The Company has also granted to the several Underwriters an option to purchase up to 875,000 additional shares of Common Stock, on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Purchase Agreement are herein collectively called the “Securities.”

THIRD AMENDMENT TO AND RESTATEMENT OF LOAN AND SECURITY AGREEMENT
Loan and Security Agreement • January 8th, 2024 • Rockwell Medical, Inc. • Pharmaceutical preparations • New York

THIS THIRD AMENDMENT TO AND RESTATEMENT OF LOAN AND SECURITY AGREEMENT (as the same may be amended, restated, modified, or supplemented from time to time, this “Agreement”), dated as of January 1, 2024 (the “Effective Date”), among INNOVATUS LIFE SCIENCES LENDING FUND I, LP, a Delaware limited partnership, as collateral agent (in such capacity, together with its successors and assigns in such capacity, “Collateral Agent”), and the Lenders listed on Schedule 1.1 hereof or otherwise a party hereto from time to time including INNOVATUS LIFE SCIENCES LENDING FUND I, LP, in its capacity as a Lender, and ROCKWELL MEDICAL, INC., a Delaware corporation (“Parent”) and ROCKWELL TRANSPORTATION, INC., a Michigan corporation and a wholly owned Subsidiary of Parent (“RTI”) (individually and collectively, jointly and severally, “Borrower”), provides the terms on which the Lenders shall agree to maintain outstanding Term Loans to Borrower and Borrower shall repay the Lenders.

1 EXHIBIT 1.1 ROCKWELL MEDICAL TECHNOLOGIES, INC. UNDERWRITING AGREEMENT
Underwriting Agreement • January 22nd, 1998 • Rockwell Medical Technologies Inc • Electromedical & electrotherapeutic apparatus • New York
AND
Underwriters' Warrant Agreement • January 22nd, 1998 • Rockwell Medical Technologies Inc • Electromedical & electrotherapeutic apparatus • New York
FORM OF INDEMNIFICATION AGREEMENT
Indemnification Agreement • August 30th, 2019 • Rockwell Medical, Inc. • Electromedical & electrotherapeutic apparatus

This Indemnification Agreement (this “Agreement”) is entered into as of (the “Effective Date”) by and between Rockwell Medical, Inc., a Delaware corporation (the “Company”), and (the “Indemnitee”).

3,191,489 Shares ROCKWELL MEDICAL, INC. Common Stock UNDERWRITING AGREEMENT
Underwriting Agreement • February 6th, 2020 • Rockwell Medical, Inc. • Electromedical & electrotherapeutic apparatus • New York

Rockwell Medical, Inc., a Delaware corporation (the “Company”), proposes to sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of 3,191,489 shares (the “Firm Shares”) of common stock, par value $0.0001 per share (the “Common Stock”), of the Company. The Company has also granted to the several Underwriters an option to purchase up to 478,723 additional shares of Common Stock, on the terms and for the purposes set forth in Section 3 hereof (the “Option Shares”). The Firm Shares and any Option Shares purchased pursuant to this Underwriting Agreement are herein collectively called the “Securities.”

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • June 2nd, 2022 • Rockwell Medical, Inc. • Pharmaceutical preparations

This Registration Rights Agreement (this “Agreement”) is made and entered into as of June 2, 2022, between Rockwell Medical, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).

Rockwell Medical Technologies, Inc. 1,845,000 Shares Common Stock (no par value) Underwriting Agreement
Underwriting Agreement • February 10th, 2012 • Rockwell Medical Technologies Inc • Electromedical & electrotherapeutic apparatus • New York

Rockwell Medical Technologies, Inc., a Michigan corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to the several underwriters named in Schedule I hereto (collectively, the “Underwriters”) for whom Stifel, Nicolaus & Company, Incorporated is acting as representative (the “Representative”), an aggregate of 1,845,000 shares (the “Shares”) of common stock, no par value per share, of the Company (the “Common Stock”).

No. W- --------------- Warrant to Purchase ________ shares of Common Stock
Warrant Agreement • November 21st, 1997 • Rockwell Medical Technologies Inc • Electromedical & electrotherapeutic apparatus
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!